PDE5A and neoplasm: Phosphodiesterase-5 (PDE5) inhibitors (e.g., sildenafil, tadalafil, vardenafil), particularly used for nonmalignant conditions in the clinic, have been found to increase anti-tumor immune responses by altering the MDSC suppressive function and restoring anti-tumor immunity (121).